Introduction
The International AIDS conferences have received a substantial amount of criticism in recent years. Particular attention has been paid to the costs and questionable benefits of such a large multidisciplinary conference.' An editorial in the Lancet commented on the high cost of the VIIIth International Conference in Amsterdam which was "ten times the WHO/GPA budget for condoms since the program was launched".2 It was suggested that such conferences were only necessary in the early 1980s when accumulation of knowledge about AIDS was rapid. Delaney, in the Newsletter of the International AIDS Society, raised the possibility of a conference attended only by those with a reason for being there. 3 The possible benefits of the conference were not discussed and we are unaware of any study which has attempted to do so. The aim of this study therefore was to determine the perceived usefulness of the conference to medical delegates from the United Kingdom, and their attitudes towards patient participation and restriction of attendance. Scored 0-10: 0 = not important; 10 = extremely important. Scored 0-10: 0 = strongly disagree; 10 = strongly agree.
There was no significant difference between responders and non-responders regarding medical speciality, seniority or location of employment.
Attitudes towards various aspects of the International AIDS conference are shown in tables 1-4. Conference attendance was reported to have increased motivation during clinical work in 43(50%) respondents, (no effect reported by 47%, n = 40, missing values = 3). Increased motivation for research was reported by 49 (57%) respondents (no change reported by 32 (37%), not applicable = 3, missing values = 2), whilst "burnout" was felt to be decreased by conference attendance by 41 There were statistically significant differences in the perceived value of the conference between GU and other physicians. GU physicians reported less change in their clinical practice as a result of attending the 1992 conference (median score 3 vs 5, z = 2.10, p = 0.04), less effect on future research (X2 = 4.60, df = 1, p = 0 032) and placed less value on the opportunity to meet non-UK medical colleagues (median score 7 vs 8, z = 2.43, p = 0.015) or UK para-medical colleagues (median score 2 vs 5, z = 2.28, p = 0 022) than did other physicians. Those who had attended two or more conferences were more likely to value the conference as a means of finding data relevant to their own research (median score 8 vs 6.5, z = 2-48, p = 0.013) and as an opportunity to meet UK (median score 7 vs 5, z = 2.86, p = 0.004) and non-UK (median score 8 vs 6, z = 4.02, p = 0.0001) medical colleagues than those who were attending the conference for the first time.
A majority of respondents would prefer a more "traditional" scientific medical meeting (55%, n = 47), 37% (n = 32) were against such a change, and 8% (n = 7) were undecided. If attendance at conferences were to be restricted, resp6ndentsgthought the following groups should be encouraged to attend: clinicians (91%, n = 78), scientists (85%, n = 73), epidemiologists (76%, n = 65), non-medical health care workers (60%, n = 51), sociologists (41%, n = 35), voluntary sector (31%, n = 27), patients (26%, n = 22).
The response to the perceived value of patient participation at the conference varied (table 4) . Overall, the majority of respondents agreed that patient participation improved discussion of ethical issues (77%, n = 66) and political issues (73%, n = 63). However, GU physicians were significantly more likely than others to feel that patient participation did not improve discussion on medical/scientific (median score 3 vs 5, z = 2-14, p = 0.032) or political (median score 5 vs 7, z = 2.17, p = 0030) issues. Senior physicians (consultants/senior lecturers) were more likely to agree that patient participation adversely affected relationships with the pharmaceutical industry (median score 5 vs 3, z = 2-11, p = 0.035), than other grades of physician.
Attendance at the IX Conference in Berlin was planned by 54%, (n = 46). The reasons given for non-attendance at Berlin were: colleagues' turn to attend (51%, n = 20), cost (39%, n = 15), conference would be of no benefit (23%, n = 9), lack of study leave (5%, n = 2), and other reasons (26%, n = 10). 
